Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPI for Preventing GERD in Seafarers
NCT04696783Phase 3Unknown
- Sponsor
- The Fifth Affiliated Hospital of Sun Yat-sen University
- Start
- Jul 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of esomeprazole in gastroesophageal reflux disease (GERD), sponsored by The Fifth Affiliated Hospital of Sun Yat-sen University. Status: unknown.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT04696783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04696783.